NeuroSense Therapeutics NRSN Cash Flow Statement (2020-2026)

NASDAQ NRSN
$2.62 +0.23 (+9.62%)
As of: Oct 21, 2026 · 10:18 AM EDT
Reported Financials

NeuroSense Therapeutics Quarterly Cash Flow Statement

Periods 17 quarters
Latest Jun 2026

NeuroSense Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 17 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Jun2025 Dec2025 Jun2026
Operating Activities
Net Income 2.50M-2.67M-3.53M-2.86M-0.29M-2.62M-5.74M5.47M-7.14M-2.99M-3.03M-2.11M-1.77M
Additional items
Ending Cash Balance 0.70M11.06M11.06M3.54M7.09M2.64M1.21M3.38M0.67M0.17M0.23M

NeuroSense Therapeutics Cash Flow Statement API

Pull NeuroSense Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NRSN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY